デフォルト表紙
市場調査レポート
商品コード
1566223

ヌートロピックの市場規模、シェア、成長分析、形態別、流通チャネル別、地域別 - 産業予測、2024年~2031年

Nootropics Market Size, Share, Growth Analysis, By Form (Capsules/Tablets, Powder), By Distribution Channel (Online, Offline), By Region - Industry Forecast 2024-2031


出版日
発行
SkyQuest
ページ情報
英文 157 Pages
納期
3~5営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
ヌートロピックの市場規模、シェア、成長分析、形態別、流通チャネル別、地域別 - 産業予測、2024年~2031年
出版日: 2024年10月03日
発行: SkyQuest
ページ情報: 英文 157 Pages
納期: 3~5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

ヌートロピックの世界市場規模は、2022年に37億7,000万米ドルと評価され、2023年の43億2,000万米ドルから2031年には128億7,000万米ドルに成長し、予測期間(2024-2031年)のCAGRは14.62%で成長する見通しです。

ヌートロピック市場は、記憶力、創造力、集中力などの精神機能の改善を目的としたさまざまな認知機能向上剤を包含しており、さまざまな層の消費者需要の増加によって著しい成長を遂げています。カフェイン、高麗人参、モダフィニルを含む天然および合成化合物は、脳への血流を促進し、神経伝達物質レベルを上昇させ、神経細胞の健康を保護することによって機能し、この分野で極めて重要な役割を果たしています。しかし、特定のヌートロピックの長期的な効果は依然不明であり、医学的管理の下でこれらの物質を使用することの重要性が強調されています。米国では、マルチビタミン・タブレットもまた、集中力や注意力のような認知機能を向上させるために成人がよく利用することから、2つの目的を兼ねています。スマート薬の人気の高まりは、dualdiagnosis.orgなどの情報源で報告されている動向にも反映されており、精神能力を高めようとする社会的傾向の高まりを浮き彫りにしています。この市場拡大には、学生や専門家の間でスマート医薬品が広く受け入れられていることがさらに拍車をかけており、認知増強剤を日常生活に取り入れる際には慎重な配慮が必要であることが強調されています。全体として、ヌートロピック市場は、精神的鋭敏さと生産性向上の追求の高まりに後押しされ、有望な成長機会を持つ急成長分野です。

目次

イントロダクション

  • 調査の目的
  • 定義
  • 市場範囲

調査手法

  • 情報調達
  • 二次データソースと一次データソース
  • 市場規模予測
  • 市場の想定と制限

エグゼクティブサマリー

  • 市場概要見通し
  • 供給需要動向分析
  • セグメント別機会分析

市場力学と見通し

  • 市場力学
    • 促進要因
    • 機会
    • 抑制要因
    • 課題
  • ポーターの分析

主な市場の考察

  • 主な成功要因
  • 競合の程度
  • 主な投資機会
  • 市場のエコシステム
  • 規制情勢
  • バリューチェーン分析
  • 主要顧客と購入基準の分析

ヌートロピック市場:形態別

  • イントロダクション
  • カプセル/錠剤
  • ドリンク
  • その他

ヌートロピック市場:流通チャネル別

  • イントロダクション
  • オフライン
  • オンライン

ヌートロピック市場規模:地域別

  • 市場概要
  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • スペイン
    • フランス
    • 英国
    • イタリア
    • その他欧州地域
  • アジア太平洋地域
    • 中国
    • インド
    • 日本
    • 韓国
    • その他アジア太平洋地域
  • ラテンアメリカ
    • ブラジル
    • その他ラテンアメリカ地域
  • 中東・アフリカ(MEA)
    • GCC諸国
    • 南アフリカ
    • その他中東・アフリカ地域

競合情勢

  • 上位5社の比較
  • 主要企業の市場ポジショニング(2023年)
  • 主な市場企業が採用した戦略
  • 市場における最近の活動
  • 主要企業の市場シェア(2023年)

主要企業プロファイル

  • Onnit Labs, Inc.
  • Reckitt Benckiser Group PLC
  • Mental Mojo, LLC
  • NooCube
  • Mind Lab Pro(Performance Lab Group Ltd)
  • TruBrain
  • Zhou Nutrition
  • Kimera Koffee
  • Purelife Bioscience Co. Ltd.
  • Nootrobox Inc.
  • Nootropic Source
  • AlternaScript LLC
  • HVMN Inc.
  • Powder City LLC
  • Nootropics Depot LLC
  • Peak Nootropics
  • Nootropic Geek LLC
  • Mind Nutrition Ltd.
  • Neurofuse Inc.
  • BrainMD Health
目次
Product Code: SQMIG35A2160

Global Nootropics Market size was valued at USD 3.77 billion in 2022 and is poised to grow from USD 4.32 billion in 2023 to USD 12.87 billion by 2031, growing at a CAGR of 14.62% during the forecast period (2024-2031).

The nootropics market, encompassing a range of cognitive enhancers aimed at improving mental functions such as memory, creativity, and focus, is witnessing significant growth driven by increased consumer demand across various demographics. Both natural and synthetic compounds, including caffeine, ginseng, and modafinil, play a pivotal role in this space, functioning by enhancing blood flow to the brain, elevating neurotransmitter levels, and protecting neuronal health. Students, professionals, and athletes are increasingly drawn to these enhancements to optimize their cognitive performance; however, the long-term effects of certain nootropics remain uncertain, underscoring the importance of using these substances under medical supervision. In the U.S., multivitamin tablets also serve a dual purpose, as adults often turn to them for improved cognitive functions like concentration and alertness. The rising popularity of smart medications is reflected in trends reported in sources such as dualdiagnosis.org, highlighting a growing societal inclination toward enhancing mental capacity. This market expansion is further fueled by the widespread acceptance of smart pharmaceuticals among students and professionals alike, emphasizing the need for careful consideration when integrating cognitive enhancers into daily routines. Overall, the nootropics market represents a burgeoning sector with promising growth opportunities, driven by the increasing pursuit of mental acuity and productivity enhancement.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Nootropics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Nootropics Market Segmental Analysis

Global Nootropics Market is segmented by Form, Distribution Channel, and region. Based on Form, the market is segmented into Capsules/Tablets, Powder, Drinks, Others. Based on Distribution Channel, the market is segmented into Online, Offline. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Nootropics Market

The global nootropics market is significantly driven by the escalating demand for cognitive enhancers, particularly among students and working professionals facing intense academic and occupational pressures. As competition rises, individuals increasingly seek solutions to enhance cognitive functions such as memory retention, creativity, and focus. Nootropics emerge as a viable option, offering benefits that boost brain performance and improve mental clarity, thereby enabling users to meet their demands effectively. Additionally, the rising prevalence of age-related cognitive decline among the elderly is further fueling market growth, as this demographic increasingly turns to nootropics to maintain cognitive health and enhance quality of life.

Restraints in the Global Nootropics Market

The global nootropics market faces significant restraints primarily due to the absence of standardization and regulatory oversight within the industry. Many nootropic substances lack approval from regulatory bodies, like the FDA, leading to heightened safety concerns among potential consumers. The unclear long-term effects of various nootropics exacerbate these apprehensions, deterring users from integrating them into their daily routines. Furthermore, inconsistencies in standardized dosages and quality control during manufacturing contribute to uncertainty regarding the effectiveness and safety of these products, undermining consumer confidence and hindering market growth in an increasingly health-conscious environment.

Market Trends of the Global Nootropics Market

The global nootropics market is poised for substantial expansion, driven by a rising appetite for cognitive enhancers from diverse demographics, including students, professionals, and the aging population. A notable trend is the increasing preference for natural and herbal nootropics as consumers prioritize health and wellness. As innovation fuels product development, companies are introducing cutting-edge supplements tailored to enhance cognitive function, further propelling market growth. However, this burgeoning sector faces challenges such as regulatory inconsistencies and a lack of standardization, which could undermine consumer trust and potentially hinder market progression in the near future.

Table of Contents

Introduction

  • Objectives of the Study
  • Definitions
  • Market Scope

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Sources
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Market Overview Outlook
  • Supply Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of Substitute Products
    • Bargaining Power of Buyers
    • Threat of New Entrants
    • Bargaining Power of Suppliers

Key Market Insights

  • Key Success Factor
  • Degree of Competition
  • Top Investment Pockets
  • Ecosystem of the Market
  • Regulatory Landscape
  • Value Chain Analysis
  • Key Customer and buying Criteria Analysis

Nootropics Market, By Form

  • Introduction
  • Capsules/Tablets
  • Powder
  • Drinks
  • Others

Nootropics Market, By Distribution Channel

  • Introduction
  • Offline
  • Online

Nootropics Market Size by Region

  • Market Overview
  • North America
    • USA
    • Canada
  • Europe
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (MEA)
    • GCC Countries
    • South Africa
    • Rest of MEA

Competitive Landscape

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2023
  • Strategies Adopted by Key Market Players
  • Recent Activities in the Market
  • Key Companies Market Share (%), 2023

Key Company Profiles

  • Onnit Labs, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Reckitt Benckiser Group PLC
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Mental Mojo, LLC
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • NooCube
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Mind Lab Pro (Performance Lab Group Ltd)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • TruBrain
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Zhou Nutrition
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Kimera Koffee
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Purelife Bioscience Co. Ltd.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Nootrobox Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Nootropic Source
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • AlternaScript LLC
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • HVMN Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Powder City LLC
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Nootropics Depot LLC
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Peak Nootropics
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Nootropic Geek LLC
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Mind Nutrition Ltd.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Neurofuse Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • BrainMD Health
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments